President Donald Trump’s White House press secretary held the first news briefing in more than a year on Friday, fielding questions on China, sexual assault...
It’s becoming more likely that the Food and Drug Administration will authorize Gilead Sciences Inc.’s remdesivir, a decade-old experimental therapy first...
Tesla Inc. CEO Elon Musk stirs fresh Twitter controversy on Friday, saying the Silicon Valley car maker’s stock was “too high,” prompting a steep decline for...
After uncovering these promising leads, the next step is human trials.
Read More...
Some indexes rebounded over 40% since the March lows and there’s now resistance holding back further gains.
Read More...
‘The institution has an obligation first and foremost to make sure that all visitors are following their guidelines for safety for both patients and their...
Gold futures on Friday head modestly lower for the day and week, with bullion defying its usual inverse correlations with a softer U.S. dollar and slumping...
Apple Inc. reported Thursday that profits slipped slightly but sales grew amid the spread of COVID-19, and promised investors billions more in stock...
Alex Ely outperforms his fund’s benchmark by selecting companies that meet his ‘better, cheaper, faster’ mantra.
Read More...
Gerald Sparrow screens companies for ‘pure units’ of sales to pick winners.
Read More...
